News
EQS-News: Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
EQS-News: Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
Almirall Launches Act4Impact – its Updated Sustainability Strategy Setting Ambitious Targets for 2030
Almirall S.A. (BME: ALM), a global pharmaceutical company dedicated to medical dermatology, launched its new sustainability strategy Act4Impact 2030 today. The updated strategy aims at transforming
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
Lockheed Martin Gives Thumbs Up to 1 Tiny Space Stock
Valued at $110 billion and doing nearly $70 billion in annual business, Lockheed Martin (NYSE: LMT) is the world's biggest defense company. It's also a major player in space.
Lockheed Martin builds
EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
EQS-News: Evotec SE: Results of the Annual General Meeting 2024
EQS-News: Evotec SE: Results of the Annual General Meeting 2024
EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-News: Evotec reports Q1 2024 results and provides corporate update
EQS-News: Evotec reports Q1 2024 results and provides corporate update
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024
EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Danville
Geisinger and Acadia Healthcare Company held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 96-bed behavioral health hospital in Danville
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q1 2024 Earnings CallMay 01, 2024, 8:00 a.m. ET
Operator
Source Fool.com